CH Term (R4)
3.3.0-ci-build - ci-build
CH Term (R4)
3.3.0-ci-build - ci-build
CH Term (R4), published by HL7 Switzerland. This guide is not an authorized publication; it is the continuous build for version 3.3.0-ci-build built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7ch/ch-term/ and changes regularly. See the Directory of published versions
| Active as of 2025-10-20 |
<ConceptMap xmlns="http://hl7.org/fhir">
<id value="ch-vacd-immunoglobulin-targetdiseases-cm"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: ConceptMap ch-vacd-immunoglobulin-targetdiseases-cm</b></p><a name="ch-vacd-immunoglobulin-targetdiseases-cm"> </a><a name="hcch-vacd-immunoglobulin-targetdiseases-cm"> </a><p>Mapping from <a href="ValueSet-ch-vacd-swissmedic-immunoglobulin-vs.html">CH VACD Swissmedic Authorized Immunoglobulin Codes</a> to <a href="ValueSet-ch-vacd-targetdiseasesandillnessesundergoneforimmunization-vs.html">CH VACD Target disease and illnesses undergone for immunization</a></p><br/><p><b>Group 1 </b>Mapping from <a href="CodeSystem-ch-vacd-swissmedic-immunoglobulin-cs.html">CH VACD Swissmedic Authorized Immunoglobulin Codes</a> to <a href="http://hl7.org/fhir/R4/codesystem-snomedct.html">SNOMED CT (all versions)</a></p><table class="grid"><tr><td colspan="2"><b>Source Concept Details</b></td><td><b>Relationship</b></td><td colspan="2"><b>Target Concept Details</b></td></tr><tr><td colspan="2"><b>Codes</b> from <a href="CodeSystem-ch-vacd-swissmedic-immunoglobulin-cs.html" title="http://fhir.ch/ig/ch-vacd/CodeSystem/ch-vacd-swissmedic-immunoglobulin-cs">CH VACD Swissmedic Authorized Immunoglobulin Codes</a></td><td/><td colspan="2"><b>Codes</b> from <a href="http://hl7.org/fhir/R4/codesystem-snomedct.html" title="http://snomed.info/sct">SNOMED CT (all versions)</a></td></tr><tr><td style="border-right-width: 0px">00687-01</td><td style="border-left-width: 0px">Berirab 2 ml, Injektionslösung</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">14168008</td><td style="border-left-width: 0px">Rabies (disorder)</td></tr><tr><td style="border-right-width: 0px">00687-02</td><td style="border-left-width: 0px">Berirab 5 ml, Injektionslösung</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">14168008</td><td style="border-left-width: 0px">Rabies (disorder)</td></tr><tr><td style="border-right-width: 0px">69039-02</td><td style="border-left-width: 0px">Beyfortus 100 mg/1 ml, solution injectable en seringue préremplie</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">55735004</td><td style="border-left-width: 0px">Respiratory syncytial virus infection (disorder)</td></tr><tr><td style="border-right-width: 0px">69039-01</td><td style="border-left-width: 0px">Beyfortus 50 mg/0.5 ml, solution injectable en seringue préremplie</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">55735004</td><td style="border-left-width: 0px">Respiratory syncytial virus infection (disorder)</td></tr><tr><td style="border-right-width: 0px; border-bottom-style: none">68222-01</td><td style="border-left-width: 0px; border-bottom-style: none">Cutaquig 165 mg/ml, Injektionslösung</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">58606001</td><td style="border-left-width: 0px">Primary immune deficiency disorder (disorder)</td></tr><tr><td style="border-right-width: 0px; border-top-style: none"/><td style="border-top-style: none; border-left-width: 0px"/><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">33286000</td><td style="border-left-width: 0px">Secondary immune deficiency disorder (disorder)</td></tr><tr><td style="border-right-width: 0px; border-bottom-style: none">65992-01</td><td style="border-left-width: 0px; border-bottom-style: none">Cuvitru 200 mg/ml, Injektionslösung</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">58606001</td><td style="border-left-width: 0px">Primary immune deficiency disorder (disorder)</td></tr><tr><td style="border-right-width: 0px; border-top-style: none"/><td style="border-top-style: none; border-left-width: 0px"/><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">33286000</td><td style="border-left-width: 0px">Secondary immune deficiency disorder (disorder)</td></tr><tr><td style="border-right-width: 0px">00506-02</td><td style="border-left-width: 0px">Cytotect CP Biotest, Infusionslösung</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">28944009</td><td style="border-left-width: 0px">Infection caused by Cytomegalovirus (disorder)</td></tr><tr><td style="border-right-width: 0px; border-bottom-style: none">00701-02</td><td style="border-left-width: 0px; border-bottom-style: none">Gammanorm, Injektionslösung</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">58606001</td><td style="border-left-width: 0px">Primary immune deficiency disorder (disorder)</td></tr><tr><td style="border-right-width: 0px; border-top-style: none"/><td style="border-top-style: none; border-left-width: 0px"/><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">16318001000119107</td><td style="border-left-width: 0px">Hypogammaglobulinemia due to multiple myeloma (disorder)</td></tr><tr><td style="border-right-width: 0px">00668-01</td><td style="border-left-width: 0px">Gamunex 10%, solution pour injection intraveineuse</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">14189004</td><td style="border-left-width: 0px">Measles (disorder)</td></tr><tr><td style="border-right-width: 0px">00488-02</td><td style="border-left-width: 0px">Hepatect CP, Infusionslösung</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">66071002</td><td style="border-left-width: 0px">Viral hepatitis type B (disorder)</td></tr><tr><td style="border-right-width: 0px">00674-01</td><td style="border-left-width: 0px">Hepatitis-B-Immunglobulin Behring, Injektionslösung</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">66071002</td><td style="border-left-width: 0px">Viral hepatitis type B (disorder)</td></tr><tr><td style="border-right-width: 0px; border-bottom-style: none">66410-01</td><td style="border-left-width: 0px; border-bottom-style: none">Hizentra 200mg/ml, Injektionslösung zur s.c. Anwendung, Fertigspritze</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">58606001</td><td style="border-left-width: 0px">Primary immune deficiency disorder (disorder)</td></tr><tr><td style="border-right-width: 0px; border-top-style: none"/><td style="border-top-style: none; border-left-width: 0px"/><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">33286000</td><td style="border-left-width: 0px">Secondary immune deficiency disorder (disorder)</td></tr><tr><td style="border-right-width: 0px; border-bottom-style: none">61547-01</td><td style="border-left-width: 0px; border-bottom-style: none">Hizentra, Injektionslösung zur s.c. Anwendung</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">58606001</td><td style="border-left-width: 0px">Primary immune deficiency disorder (disorder)</td></tr><tr><td style="border-right-width: 0px; border-top-style: none"/><td style="border-top-style: none; border-left-width: 0px"/><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">33286000</td><td style="border-left-width: 0px">Secondary immune deficiency disorder (disorder)</td></tr><tr><td style="border-right-width: 0px; border-bottom-style: none">66684-01</td><td style="border-left-width: 0px; border-bottom-style: none">HyQvia 100 mg/ml, Infusionslösung zur subkutanen Anwendung</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">58606001</td><td style="border-left-width: 0px">Primary immune deficiency disorder (disorder)</td></tr><tr><td style="border-right-width: 0px; border-top-style: none"/><td style="border-top-style: none; border-left-width: 0px"/><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">33286000</td><td style="border-left-width: 0px">Secondary immune deficiency disorder (disorder)</td></tr><tr><td style="border-right-width: 0px; border-bottom-style: none">58157-01</td><td style="border-left-width: 0px; border-bottom-style: none">Ig Vena Kedrion 50 g/I, solution pour infusion</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">58606001</td><td style="border-left-width: 0px">Primary immune deficiency disorder (disorder)</td></tr><tr><td style="border-right-width: 0px; border-top-style: none"/><td style="border-top-style: none; border-left-width: 0px"/><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">33286000</td><td style="border-left-width: 0px">Secondary immune deficiency disorder (disorder)</td></tr><tr><td style="border-right-width: 0px; border-bottom-style: none">62913-01</td><td style="border-left-width: 0px; border-bottom-style: none">Intratect 10%, Infusionslösung</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">58606001</td><td style="border-left-width: 0px">Primary immune deficiency disorder (disorder)</td></tr><tr><td style="border-right-width: 0px; border-top-style: none"/><td style="border-top-style: none; border-left-width: 0px"/><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">33286000</td><td style="border-left-width: 0px">Secondary immune deficiency disorder (disorder)</td></tr><tr><td style="border-right-width: 0px; border-bottom-style: none">57676-01</td><td style="border-left-width: 0px; border-bottom-style: none">Intratect 5%, Infusionslösung</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">58606001</td><td style="border-left-width: 0px">Primary immune deficiency disorder (disorder)</td></tr><tr><td style="border-right-width: 0px; border-top-style: none"/><td style="border-top-style: none; border-left-width: 0px"/><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">33286000</td><td style="border-left-width: 0px">Secondary immune deficiency disorder (disorder)</td></tr><tr><td style="border-right-width: 0px; border-bottom-style: none">66332-03</td><td style="border-left-width: 0px; border-bottom-style: none">Iqymune 10g/100ml, Infusionslösung</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">58606001</td><td style="border-left-width: 0px">Primary immune deficiency disorder (disorder)</td></tr><tr><td style="border-right-width: 0px; border-top-style: none"/><td style="border-top-style: none; border-left-width: 0px"/><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">33286000</td><td style="border-left-width: 0px">Secondary immune deficiency disorder (disorder)</td></tr><tr><td style="border-right-width: 0px; border-bottom-style: none">66332-04</td><td style="border-left-width: 0px; border-bottom-style: none">Iqymune 20g/200ml, Infusionslösung</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">58606001</td><td style="border-left-width: 0px">Primary immune deficiency disorder (disorder)</td></tr><tr><td style="border-right-width: 0px; border-top-style: none"/><td style="border-top-style: none; border-left-width: 0px"/><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">33286000</td><td style="border-left-width: 0px">Secondary immune deficiency disorder (disorder)</td></tr><tr><td style="border-right-width: 0px; border-bottom-style: none">66332-01</td><td style="border-left-width: 0px; border-bottom-style: none">Iqymune 2g/20ml, Infusionslösung</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">58606001</td><td style="border-left-width: 0px">Primary immune deficiency disorder (disorder)</td></tr><tr><td style="border-right-width: 0px; border-top-style: none"/><td style="border-top-style: none; border-left-width: 0px"/><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">33286000</td><td style="border-left-width: 0px">Secondary immune deficiency disorder (disorder)</td></tr><tr><td style="border-right-width: 0px; border-bottom-style: none">66332-02</td><td style="border-left-width: 0px; border-bottom-style: none">Iqymune 5g/50ml, Infusionslösung</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">58606001</td><td style="border-left-width: 0px">Primary immune deficiency disorder (disorder)</td></tr><tr><td style="border-right-width: 0px; border-top-style: none"/><td style="border-top-style: none; border-left-width: 0px"/><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">33286000</td><td style="border-left-width: 0px">Secondary immune deficiency disorder (disorder)</td></tr><tr><td style="border-right-width: 0px; border-bottom-style: none">57469-01</td><td style="border-left-width: 0px; border-bottom-style: none">Kiovig, Infusionslösung</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">58606001</td><td style="border-left-width: 0px">Primary immune deficiency disorder (disorder)</td></tr><tr><td style="border-right-width: 0px; border-top-style: none"/><td style="border-top-style: none; border-left-width: 0px"/><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">33286000</td><td style="border-left-width: 0px">Secondary immune deficiency disorder (disorder)</td></tr><tr><td style="border-right-width: 0px; border-bottom-style: none">60323-01</td><td style="border-left-width: 0px; border-bottom-style: none">Octagam 10 %, Lösung zur intravenösen Anwendung</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">58606001</td><td style="border-left-width: 0px">Primary immune deficiency disorder (disorder)</td></tr><tr><td style="border-right-width: 0px; border-top-style: none"/><td style="border-top-style: none; border-left-width: 0px"/><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">33286000</td><td style="border-left-width: 0px">Secondary immune deficiency disorder (disorder)</td></tr><tr><td style="border-right-width: 0px; border-bottom-style: none">58314-01</td><td style="border-left-width: 0px; border-bottom-style: none">Privigen, Infusionslösung</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">58606001</td><td style="border-left-width: 0px">Primary immune deficiency disorder (disorder)</td></tr><tr><td style="border-right-width: 0px; border-top-style: none"/><td style="border-top-style: none; border-left-width: 0px"/><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">33286000</td><td style="border-left-width: 0px">Secondary immune deficiency disorder (disorder)</td></tr><tr><td style="border-right-width: 0px">53609-02</td><td style="border-left-width: 0px">Rhophylac 300, Injektionslösung</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">165746003</td><td style="border-left-width: 0px">RhD negative (finding)</td></tr><tr><td style="border-right-width: 0px">65695-02</td><td style="border-left-width: 0px">Synagis 100 mg/1 ml, Injektionslösung</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">55735004</td><td style="border-left-width: 0px">Respiratory syncytial virus infection (disorder)</td></tr><tr><td style="border-right-width: 0px">65695-01</td><td style="border-left-width: 0px">Synagis 50 mg/0.5 ml, Injektionslösung</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">55735004</td><td style="border-left-width: 0px">Respiratory syncytial virus infection (disorder)</td></tr><tr><td style="border-right-width: 0px">00673-02</td><td style="border-left-width: 0px">Tetagam P, Injektionslösung</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">76902006</td><td style="border-left-width: 0px">Tetanus (disorder)</td></tr><tr><td style="border-right-width: 0px">59374-01</td><td style="border-left-width: 0px">Uman Big 180 UI/1 ml, solution pour injection intramusculaire</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">66071002</td><td style="border-left-width: 0px">Viral hepatitis type B (disorder)</td></tr><tr><td style="border-right-width: 0px">59374-02</td><td style="border-left-width: 0px">Uman Big 540 UI/3 ml, solution pour injection intramusculaire</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">66071002</td><td style="border-left-width: 0px">Viral hepatitis type B (disorder)</td></tr><tr><td style="border-right-width: 0px">59451-01</td><td style="border-left-width: 0px">Varitect CP, Lösung zur intravenösen Injektion</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">38907003</td><td style="border-left-width: 0px">Varicella (disorder)</td></tr><tr><td style="border-right-width: 0px">59373-02</td><td style="border-left-width: 0px">Venbig 2500 U.I/50 ml, poudre et solution pour injection intraveineuse</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">66071002</td><td style="border-left-width: 0px">Viral hepatitis type B (disorder)</td></tr><tr><td style="border-right-width: 0px">59373-01</td><td style="border-left-width: 0px">Venbig 500 U.I/10 ml, poudre et solution pour injection intraveineuse</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">66071002</td><td style="border-left-width: 0px">Viral hepatitis type B (disorder)</td></tr><tr><td style="border-right-width: 0px">68471-01</td><td style="border-left-width: 0px">Xevudy, Konzentrat zur Herstellung einer Infusionslösung</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">840539006</td><td style="border-left-width: 0px">Disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder)</td></tr><tr><td style="border-right-width: 0px">66344-01</td><td style="border-left-width: 0px">Zinplava, Konzentrat zur Herstellung einer Infusionslösung</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">56688005</td><td style="border-left-width: 0px">Clostridial infection (disorder)</td></tr><tr><td style="border-right-width: 0px">61639-01</td><td style="border-left-width: 0px">Zutectra, Injektionslösung</td><td><a href="http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto" title="relatedto">is related to</a></td><td style="border-right-width: 0px">66071002</td><td style="border-left-width: 0px">Viral hepatitis type B (disorder)</td></tr></table></div>
</text>
<url
value="http://fhir.ch/ig/ch-vacd/ConceptMap/ch-vacd-immunoglobulin-targetdiseases-cm"/>
<version value="3.3.0-ci-build"/>
<name value="ImmunGlobulineToTargetDiseaseMapping"/>
<title value="ImmunGlobuline To TargetDisease Mapping"/>
<status value="active"/>
<experimental value="false"/>
<date value="2025-10-20T19:09:01+00:00"/>
<publisher value="HL7 Switzerland"/>
<contact>
<name value="HL7 Switzerland"/>
<telecom>
<system value="url"/>
<value value="https://www.hl7.ch/"/>
</telecom>
</contact>
<contact>
<name value="HL7 Switzerland"/>
<telecom>
<system value="url"/>
<value value="https://www.hl7.ch/"/>
<use value="work"/>
</telecom>
</contact>
<description
value="Mappings from ImmunGlobuline to TargetDisease according to the correcsponding valuesets"/>
<jurisdiction>
<coding>
<system value="urn:iso:std:iso:3166"/>
<code value="CH"/>
</coding>
</jurisdiction>
<copyright
value="This artefact includes content from SNOMED Clinical Terms® (SNOMED CT®) which is copyright of the International Health Terminology Standards Development Organisation (IHTSDO). Implementers of these artefacts must have the appropriate SNOMED CT Affiliate license - for more information contact http://www.snomed.org/snomed-ct/getsnomed-ct or info@snomed.org."/>
<sourceUri
value="http://fhir.ch/ig/ch-vacd/ValueSet/ch-vacd-swissmedic-immunoglobulin-vs"/>
<targetUri
value="http://fhir.ch/ig/ch-vacd/ValueSet/ch-vacd-targetdiseasesandillnessesundergoneforimmunization-vs"/>
<group>
<source
value="http://fhir.ch/ig/ch-vacd/CodeSystem/ch-vacd-swissmedic-immunoglobulin-cs"/>
<target value="http://snomed.info/sct"/>
<element>
<code value="00687-01"/>
<display value="Berirab 2 ml, Injektionslösung"/>
<target>
<code value="14168008"/>
<display value="Rabies (disorder)"/>
<equivalence value="relatedto"/>
</target>
</element>
<element>
<code value="00687-02"/>
<display value="Berirab 5 ml, Injektionslösung"/>
<target>
<code value="14168008"/>
<display value="Rabies (disorder)"/>
<equivalence value="relatedto"/>
</target>
</element>
<element>
<code value="69039-02"/>
<display
value="Beyfortus 100 mg/1 ml, solution injectable en seringue préremplie"/>
<target>
<code value="55735004"/>
<display value="Respiratory syncytial virus infection (disorder)"/>
<equivalence value="relatedto"/>
</target>
</element>
<element>
<code value="69039-01"/>
<display
value="Beyfortus 50 mg/0.5 ml, solution injectable en seringue préremplie"/>
<target>
<code value="55735004"/>
<display value="Respiratory syncytial virus infection (disorder)"/>
<equivalence value="relatedto"/>
</target>
</element>
<element>
<code value="68222-01"/>
<display value="Cutaquig 165 mg/ml, Injektionslösung"/>
<target>
<code value="58606001"/>
<display value="Primary immune deficiency disorder (disorder)"/>
<equivalence value="relatedto"/>
</target>
<target>
<code value="33286000"/>
<display value="Secondary immune deficiency disorder (disorder)"/>
<equivalence value="relatedto"/>
</target>
</element>
<element>
<code value="65992-01"/>
<display value="Cuvitru 200 mg/ml, Injektionslösung"/>
<target>
<code value="58606001"/>
<display value="Primary immune deficiency disorder (disorder)"/>
<equivalence value="relatedto"/>
</target>
<target>
<code value="33286000"/>
<display value="Secondary immune deficiency disorder (disorder)"/>
<equivalence value="relatedto"/>
</target>
</element>
<element>
<code value="00506-02"/>
<display value="Cytotect CP Biotest, Infusionslösung"/>
<target>
<code value="28944009"/>
<display value="Infection caused by Cytomegalovirus (disorder)"/>
<equivalence value="relatedto"/>
</target>
</element>
<element>
<code value="00701-02"/>
<display value="Gammanorm, Injektionslösung"/>
<target>
<code value="58606001"/>
<display value="Primary immune deficiency disorder (disorder)"/>
<equivalence value="relatedto"/>
</target>
<target>
<code value="16318001000119107"/>
<display
value="Hypogammaglobulinemia due to multiple myeloma (disorder)"/>
<equivalence value="relatedto"/>
</target>
</element>
<element>
<code value="00668-01"/>
<display value="Gamunex 10%, solution pour injection intraveineuse"/>
<target>
<code value="14189004"/>
<display value="Measles (disorder)"/>
<equivalence value="relatedto"/>
</target>
</element>
<element>
<code value="00488-02"/>
<display value="Hepatect CP, Infusionslösung"/>
<target>
<code value="66071002"/>
<display value="Viral hepatitis type B (disorder)"/>
<equivalence value="relatedto"/>
</target>
</element>
<element>
<code value="00674-01"/>
<display value="Hepatitis-B-Immunglobulin Behring, Injektionslösung"/>
<target>
<code value="66071002"/>
<display value="Viral hepatitis type B (disorder)"/>
<equivalence value="relatedto"/>
</target>
</element>
<element>
<code value="66410-01"/>
<display
value="Hizentra 200mg/ml, Injektionslösung zur s.c. Anwendung, Fertigspritze"/>
<target>
<code value="58606001"/>
<display value="Primary immune deficiency disorder (disorder)"/>
<equivalence value="relatedto"/>
</target>
<target>
<code value="33286000"/>
<display value="Secondary immune deficiency disorder (disorder)"/>
<equivalence value="relatedto"/>
</target>
</element>
<element>
<code value="61547-01"/>
<display value="Hizentra, Injektionslösung zur s.c. Anwendung"/>
<target>
<code value="58606001"/>
<display value="Primary immune deficiency disorder (disorder)"/>
<equivalence value="relatedto"/>
</target>
<target>
<code value="33286000"/>
<display value="Secondary immune deficiency disorder (disorder)"/>
<equivalence value="relatedto"/>
</target>
</element>
<element>
<code value="66684-01"/>
<display
value="HyQvia 100 mg/ml, Infusionslösung zur subkutanen Anwendung"/>
<target>
<code value="58606001"/>
<display value="Primary immune deficiency disorder (disorder)"/>
<equivalence value="relatedto"/>
</target>
<target>
<code value="33286000"/>
<display value="Secondary immune deficiency disorder (disorder)"/>
<equivalence value="relatedto"/>
</target>
</element>
<element>
<code value="58157-01"/>
<display value="Ig Vena Kedrion 50 g/I, solution pour infusion"/>
<target>
<code value="58606001"/>
<display value="Primary immune deficiency disorder (disorder)"/>
<equivalence value="relatedto"/>
</target>
<target>
<code value="33286000"/>
<display value="Secondary immune deficiency disorder (disorder)"/>
<equivalence value="relatedto"/>
</target>
</element>
<element>
<code value="62913-01"/>
<display value="Intratect 10%, Infusionslösung"/>
<target>
<code value="58606001"/>
<display value="Primary immune deficiency disorder (disorder)"/>
<equivalence value="relatedto"/>
</target>
<target>
<code value="33286000"/>
<display value="Secondary immune deficiency disorder (disorder)"/>
<equivalence value="relatedto"/>
</target>
</element>
<element>
<code value="57676-01"/>
<display value="Intratect 5%, Infusionslösung"/>
<target>
<code value="58606001"/>
<display value="Primary immune deficiency disorder (disorder)"/>
<equivalence value="relatedto"/>
</target>
<target>
<code value="33286000"/>
<display value="Secondary immune deficiency disorder (disorder)"/>
<equivalence value="relatedto"/>
</target>
</element>
<element>
<code value="66332-03"/>
<display value="Iqymune 10g/100ml, Infusionslösung"/>
<target>
<code value="58606001"/>
<display value="Primary immune deficiency disorder (disorder)"/>
<equivalence value="relatedto"/>
</target>
<target>
<code value="33286000"/>
<display value="Secondary immune deficiency disorder (disorder)"/>
<equivalence value="relatedto"/>
</target>
</element>
<element>
<code value="66332-04"/>
<display value="Iqymune 20g/200ml, Infusionslösung"/>
<target>
<code value="58606001"/>
<display value="Primary immune deficiency disorder (disorder)"/>
<equivalence value="relatedto"/>
</target>
<target>
<code value="33286000"/>
<display value="Secondary immune deficiency disorder (disorder)"/>
<equivalence value="relatedto"/>
</target>
</element>
<element>
<code value="66332-01"/>
<display value="Iqymune 2g/20ml, Infusionslösung"/>
<target>
<code value="58606001"/>
<display value="Primary immune deficiency disorder (disorder)"/>
<equivalence value="relatedto"/>
</target>
<target>
<code value="33286000"/>
<display value="Secondary immune deficiency disorder (disorder)"/>
<equivalence value="relatedto"/>
</target>
</element>
<element>
<code value="66332-02"/>
<display value="Iqymune 5g/50ml, Infusionslösung"/>
<target>
<code value="58606001"/>
<display value="Primary immune deficiency disorder (disorder)"/>
<equivalence value="relatedto"/>
</target>
<target>
<code value="33286000"/>
<display value="Secondary immune deficiency disorder (disorder)"/>
<equivalence value="relatedto"/>
</target>
</element>
<element>
<code value="57469-01"/>
<display value="Kiovig, Infusionslösung"/>
<target>
<code value="58606001"/>
<display value="Primary immune deficiency disorder (disorder)"/>
<equivalence value="relatedto"/>
</target>
<target>
<code value="33286000"/>
<display value="Secondary immune deficiency disorder (disorder)"/>
<equivalence value="relatedto"/>
</target>
</element>
<element>
<code value="60323-01"/>
<display value="Octagam 10 %, Lösung zur intravenösen Anwendung"/>
<target>
<code value="58606001"/>
<display value="Primary immune deficiency disorder (disorder)"/>
<equivalence value="relatedto"/>
</target>
<target>
<code value="33286000"/>
<display value="Secondary immune deficiency disorder (disorder)"/>
<equivalence value="relatedto"/>
</target>
</element>
<element>
<code value="58314-01"/>
<display value="Privigen, Infusionslösung"/>
<target>
<code value="58606001"/>
<display value="Primary immune deficiency disorder (disorder)"/>
<equivalence value="relatedto"/>
</target>
<target>
<code value="33286000"/>
<display value="Secondary immune deficiency disorder (disorder)"/>
<equivalence value="relatedto"/>
</target>
</element>
<element>
<code value="53609-02"/>
<display value="Rhophylac 300, Injektionslösung"/>
<target>
<code value="165746003"/>
<display value="RhD negative (finding)"/>
<equivalence value="relatedto"/>
</target>
</element>
<element>
<code value="65695-02"/>
<display value="Synagis 100 mg/1 ml, Injektionslösung"/>
<target>
<code value="55735004"/>
<display value="Respiratory syncytial virus infection (disorder)"/>
<equivalence value="relatedto"/>
</target>
</element>
<element>
<code value="65695-01"/>
<display value="Synagis 50 mg/0.5 ml, Injektionslösung"/>
<target>
<code value="55735004"/>
<display value="Respiratory syncytial virus infection (disorder)"/>
<equivalence value="relatedto"/>
</target>
</element>
<element>
<code value="00673-02"/>
<display value="Tetagam P, Injektionslösung"/>
<target>
<code value="76902006"/>
<display value="Tetanus (disorder)"/>
<equivalence value="relatedto"/>
</target>
</element>
<element>
<code value="59374-01"/>
<display
value="Uman Big 180 UI/1 ml, solution pour injection intramusculaire"/>
<target>
<code value="66071002"/>
<display value="Viral hepatitis type B (disorder)"/>
<equivalence value="relatedto"/>
</target>
</element>
<element>
<code value="59374-02"/>
<display
value="Uman Big 540 UI/3 ml, solution pour injection intramusculaire"/>
<target>
<code value="66071002"/>
<display value="Viral hepatitis type B (disorder)"/>
<equivalence value="relatedto"/>
</target>
</element>
<element>
<code value="59451-01"/>
<display value="Varitect CP, Lösung zur intravenösen Injektion"/>
<target>
<code value="38907003"/>
<display value="Varicella (disorder)"/>
<equivalence value="relatedto"/>
</target>
</element>
<element>
<code value="59373-02"/>
<display
value="Venbig 2500 U.I/50 ml, poudre et solution pour injection intraveineuse"/>
<target>
<code value="66071002"/>
<display value="Viral hepatitis type B (disorder)"/>
<equivalence value="relatedto"/>
</target>
</element>
<element>
<code value="59373-01"/>
<display
value="Venbig 500 U.I/10 ml, poudre et solution pour injection intraveineuse"/>
<target>
<code value="66071002"/>
<display value="Viral hepatitis type B (disorder)"/>
<equivalence value="relatedto"/>
</target>
</element>
<element>
<code value="68471-01"/>
<display
value="Xevudy, Konzentrat zur Herstellung einer Infusionslösung"/>
<target>
<code value="840539006"/>
<display
value="Disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder)"/>
<equivalence value="relatedto"/>
</target>
</element>
<element>
<code value="66344-01"/>
<display
value="Zinplava, Konzentrat zur Herstellung einer Infusionslösung"/>
<target>
<code value="56688005"/>
<display value="Clostridial infection (disorder)"/>
<equivalence value="relatedto"/>
</target>
</element>
<element>
<code value="61639-01"/>
<display value="Zutectra, Injektionslösung"/>
<target>
<code value="66071002"/>
<display value="Viral hepatitis type B (disorder)"/>
<equivalence value="relatedto"/>
</target>
</element>
</group>
</ConceptMap>